These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11151889)

  • 1. The impact of previous HBV infection on the course of chronic hepatitis C.
    De Maria N; Colantoni A; Friedlander L; Leandro G; Idilman R; Harig J; Van Thiel DH
    Am J Gastroenterol; 2000 Dec; 95(12):3529-36. PubMed ID: 11151889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.
    Levast M; Larrat S; Thelu MA; Nicod S; Plages A; Cheveau A; Zarski JP; Seigneurin JM; Morand P; Leroy V
    J Med Virol; 2010 May; 82(5):747-54. PubMed ID: 20336715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
    Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
    J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Previous Exposure to HBV on Liver Histology and Treatment Response in CHC Patients.
    Khan HA; Umar M; Hamama-tul-Bushra ; Ahmed M; Ambreen S
    J Coll Physicians Surg Pak; 2015 Jul; 25(7):498-500. PubMed ID: 26208552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.
    Fabris P; Brown D; Tositti G; Bozzola L; Giordani MT; Bevilacqua P; de Lalla F; Webster GJ; Dusheiko G
    J Clin Virol; 2004 Mar; 29(3):160-6. PubMed ID: 14962784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients.
    Silva Cd; Gonçales NS; Pereira JS; Escanhoela CA; Pavan MH; Gonçales FL
    Braz J Infect Dis; 2004 Dec; 8(6):431-9. PubMed ID: 15880234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
    Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
    Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
    J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment.
    Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Stanzione M; Filippini P; Felaco FM; Piccinino F
    J Med Virol; 2001 Dec; 65(4):681-7. PubMed ID: 11745931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients.
    Giannini E; Ceppa P; Botta F; Fasoli A; Romagnoli P; Ansaldi F; Durando P; Risso D; Lantieri PB; Icardi GC; Testa R
    Liver Int; 2003 Feb; 23(1):12-8. PubMed ID: 12640722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.
    Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Filippini P; Piccinino F
    J Med Virol; 2001 Jul; 64(3):350-5. PubMed ID: 11424125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
    Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
    Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C.
    Uyanikoglu A; Akyuz F; Baran B; Simsek BP; Ermis F; Demir K; Gulluoglu M; Badur S; Kaymakoglu S
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):485-90. PubMed ID: 23665172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.
    Mrani S; Chemin I; Menouar K; Guillaud O; Pradat P; Borghi G; Trabaud MA; Chevallier P; Chevallier M; Zoulim F; Trépo C
    J Med Virol; 2007 Aug; 79(8):1075-81. PubMed ID: 17596829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.
    Mandour M; Nemr N; Shehata A; Kishk R; Badran D; Hawass N
    Rev Soc Bras Med Trop; 2015; 48(3):258-64. PubMed ID: 26108002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of occult HBV infection in patients with chronic hepatitis C.
    Anwar W; Sarwar M; Hussain AB; Tariq WU; Saif M
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):192-5. PubMed ID: 16542598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.